Marijuana Abuse Clinical Trial
Official title:
Motivational Interviews for Incarcerated Teens
The purpose of this study is to test the efficacy of an individual motivational interview for reducing alcohol and marijuana-related harm as well as alcohol and marijuana use in incarcerated teens.
The objective of this research is to investigate ways to enhance motivation for treatment
and effectively reduce substance abuse among juvenile offenders. Motivational intervention
(MI) as preparation for residential treatment and for persons (including teens) with little
motivation to change has been effective in reducing substance abuse. Thus, MI designed for
delinquent youths who are required to attend substance abuse treatment may prove
efficacious.
In this proposed randomized trial, a one-way design (MI + Standard Care [SC] v. Attention
Control [AC] + SC) will be used to determine whether MI enhances subsequent treatment
participation and reduces substance-related problems post discharge in substance using,
delinquent youths. Teens will also receive a booster session of MI or AC prior to discharge.
Primary outcome variables include alcohol and marijuana use, as well as related behaviors
(illegal activity, sex or injuries while drunk or high). It is hypothesized that in
comparison to teens receiving AC, youths receiving MI will participate more (by therapist
and teen ratings) in SC and will show the lowest levels of heavy substance use and related
problems after discharge. It is hypothesized that these effects will be mediated by stage of
change, drug effect expectancies and self-efficacy.
This study will extend previous research by evaluating the use of MI with substance abusing
teens in a correctional facility, and by expanding outcome measures to include alcohol and
marijuana-related risk behavior (such as injuries and illegal activity when drunk or high)
in this population. The development of effective interventions for substance using juvenile
offenders has the potential to reduce substance abuse and crime in this population.
;
Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT00158249 -
Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals
|
Phase 2 | |
Completed |
NCT00842985 -
Dronabinol Interactions in Humans
|
N/A | |
Completed |
NCT00484302 -
Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis
|
N/A | |
Completed |
NCT00218478 -
Evaluating Responses to Drug-Related Cues Versus Neutral Cues to Understand the Effects of Marijuana Craving - 1
|
Phase 1 | |
Completed |
NCT00227903 -
Therapeutic Substance Abuse Treatment in Pregnancy - 1
|
Phase 2 | |
Completed |
NCT00227864 -
A Brief Marijuana Intervention for Adolescent Women - 1
|
Phase 3 | |
Completed |
NCT00249509 -
Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals
|
Phase 2 | |
Completed |
NCT03717272 -
Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
|
Phase 2 | |
Completed |
NCT00142961 -
Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder
|
Phase 2 | |
Terminated |
NCT02102230 -
CBT-I for Cannabis Use
|
N/A | |
Completed |
NCT00580671 -
Treatment for Adolescent Marijuana Abuse
|
N/A | |
Completed |
NCT00360269 -
Atomoxetine Treatment for ADHD and Marijuana Dependence
|
Phase 2 | |
Completed |
NCT03154567 -
Effects of Stress and Drug-cue Exposure (SCM)
|
Phase 1 | |
Active, not recruiting |
NCT05322941 -
Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
|
Phase 2 | |
Completed |
NCT02797990 -
Conflict Between Maternal Autonomy and Child Health in Substance-use
|
N/A | |
Completed |
NCT01762696 -
A Real-time, Contextual Intervention Using Mobile Technology to Reduce Marijuana Use in Youth
|
N/A | |
Completed |
NCT03154580 -
Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users
|
Phase 1 | |
Completed |
NCT00217971 -
Dronabinol Treatment for Marijuana Addiction
|
Phase 2 | |
Completed |
NCT00142870 -
Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
|
Phase 2 |